179 Results

People

  1. Motzer
    Motzer
  2. De Angelis
    De Angelis
  3. Abrey
    Abrey
  4. Panageas
    Panageas
  5. Giralt
    Giralt
  6. Kris
    Kris
  7. Sauter
    Sauter
  8. Beal
    Beal
  9. Omuro
    Omuro
  10. Perales
    Perales

Groups

  1. Department of Medicine (102)
  2. Solid Tumor Oncology Division (66)
  3. Epidemiology and Biostatistics (46)
  4. Survivorship Research (44)
  5. Biostatistics Service (43)
  6. Hematologic Malignancies, Division of (41)
  7. Center for Hematologic Malignancies (39)
  8. Population Sciences Research Program (30)
  9. Genitourinary Oncology Service (28)
  10. Radiation Oncology, Department of (27)
  1. "karnofsky performance status"
Formats
  1. Journal Article (168)
  2. Review (5)
  3. Research Letter (2)
  4. Conference Paper (1)
  5. Correspondence (1)
  6. Editorial (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (102)
  2. Solid Tumor Oncology Division (66)
  3. Epidemiology and Biostatistics (46)
  4. Survivorship Research (44)
  5. Biostatistics Service (43)
  6. Hematologic Malignancies, Division of (41)

More Groups

People
  1. Robert Motzer (19)
  2. Lisa De Angelis (18)
  3. Lauren Abrey (17)
  4. Katherine Panageas (14)
  5. Sergio Giralt (10)
  6. Mark Kris (9)

More People

Years
  1. 2025 (8)
  2. 2024 (19)
  3. 2023 (8)
  4. 2022 (8)
  5. 2021 (4)
  6. 2020 (8)

More Years

Publications
  1. Journal of Neuro-Oncology (17)
  2. Journal of Clinical Oncology (16)
  3. Cancer (10)
  4. International Journal of Radiation Oncology, Biology, Physics (8)
  5. Annals of Oncology (6)
  6. Transplantation and Cellular Therapy (6)

More Publications

Publishers
  1. Elsevier Inc. (35)
  2. Springer (24)
  3. American Society of Clinical Oncology (17)
  4. Oxford University Press (15)
  5. Wiley Blackwell (13)
  6. Elsevier Science, Inc. (12)

More Publishers

Results (179)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A multicenter, phase II, randomized, noncomparative clinical trial of radiation and temozolomide with or without vandetanib in newly diagnosed glioblastoma patients
    Journal Article

    Lee, E. Q.; Kaley, T. J.; Duda, D. G.; Schiff, D.; Lassman, A. B.; Wong, E. T.; Mikkelsen, T.; Purow, B. W.; Muzikansky, A.; Ancukiewicz, M.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers
    Journal Article

    Lok, B. H.; Jiang, G.; Gutiontov, S.; Lanning, R. M.; Sridhara, S.; Sherman, E. J.; Tsai, C. J.; McBride, S. M.; Riaz, N.; Lee, N. Y.
    Oral Oncology (2015)

    Fulltext@MSK | Save
  • Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib
    Journal Article

    Naidoo, J.; Sima, C. S.; Rodriguez, K.; Busby, N.; Nafa, K.; Ladanyi, M.; Riely, G. J.; Kris, M. G.; Arcila, M. E.; Yu, H. A.
    Cancer (2015)

    Fulltext@MSK | Save
  • FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer
    Journal Article

    Kohutek, Z. A.; Wu, A. J.; Zhang, Z.; Foster, A.; Din, S. U.; Yorke, E. D.; Downey, R.; Rosenzweig, K. E.; Weber, W. A.; Rimner, A.
    Lung Cancer (2015)

    Fulltext@MSK | Save
  • IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma
    Journal Article

    Xu, C. F.; Johnson, T.; Garcia-Donas, J.; Choueiri, T. K.; Sternberg, C. N.; Davis, I. D.; Bing, N.; Deen, K. C.; Xue, Z.; McCann, L.; more...
    British Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)
    Journal Article

    Lassman, A. B.; Pugh, S. L.; Gilbert, M. R.; Aldape, K. D.; Geinoz, S.; Beumer, J. H.; Christner, S. M.; Komaki, R.; Deangelis, L. M.; Gaur, R.; more...
    Neuro-Oncology (2015)

    Fulltext@MSK | Save
  • Differences in the survival of patients with recurrent versus de novo metastatic KRAS-mutant and EGFR-mutant lung adenocarcinomas
    Journal Article

    Yu, H. A.; Sima, C. S.; Hellmann, M. D.; Naidoo, J.; Busby, N.; Rodriguez, K.; Riely, G. J.; Kris, M. G.
    Cancer (2015)

    Fulltext@MSK | Save
  • R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma
    Journal Article

    Omuro, A.; Correa, D. D.; Deangelis, L. M.; Moskowitz, C. H.; Matasar, M. J.; Kaley, T. J.; Gavrilovic, I. T.; Nolan, C.; Pentsova, E.; Grommes, C. C.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Survival of patients treated with radiation therapy for anaplastic astrocytoma
    Journal Article

    Barker, C. A.; Chang, M.; Beal, K.; Chan, T. A.
    Radiology and Oncology (2014)

    Fulltext@MSK | Save
  • 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Beylergil, V.; Lyashchenko, S.; Ruan, S.; Solomon, S. B.; Durack, J. C.; Carrasquillo, J. A.; Lefkowitz, R. A.; Gonen, M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2014)

    Fulltext@MSK | Save